NRNadan Rustemović

Nadan Rustemović

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nadan Rustemović has a total of 70 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 19 September 2015
      • Vol. 137, 156-62

    [PREDICTORS OF POOR BOWEL PREPARATION FOR COLONOSCOPY: A SINGLE-CENTRE PROSPECTIVE STUDY].

    by Jadranka Brljak, Hrvoje Iveković, Branko Bilić, Ivana Kovačić, Pave Markoš, Tomislav Brkić, Rajko Ostojić, Nadan Rustemović

    Adequate bowel preparation is the key of a successful colonoscopy. The aim of the study was to analyze sociodemographic and clinical characteristics in our population of patients referred for colonoscopy. Bowel cleanness was evaluated using the Boston Bowel Preparation Scale (BBPS) where values 7 were considered a criterion of successful bowel preparation. The study involved 286 subjects (61.5% male, median 61 years, interquartile range 50-71). BBPS score 7 was found in 145 subjects (50.7%). Multivariate analysis indicated that subjects with severe comorbidity (ASA status 3, OR = 0,29; 95% CI: 0.12-0.72; p = 0,008) represented a risk factor for poor bowel preparation. Regimens with polyethyleneglycol (PEG) were superior compared with other protocols (OR = 2.54; 95% CI: 1.27-5.10; p = 0.008). Timing of the colonoscopy also contributed to better bowel preparation (OR = 5.50; 95% CI: 2.07-14.67; p = 0.001). This study confirms that presence of comorbidity and non-use of PEG regimens are predictors of poor bowel preparation in our population of patients referred for colonoscopy.

    • 19 September 2015
      • Vol. 137, 168-70

    [COLONIC MUCO-SUBMUCOSAL ELONGATED POLYP: A CASE REPORT AND LITERATURE REVIEW].

    by Marina Peklić Iveković, Bojana Radulović, Iva Brčić, Jasminka Jakic Razumović, Nadan Rustemović, Hrvoje Iveković

    Recently a new entity has been described--a colonic muco-submucosal elongated polyp (CMSEP)--that did not fall into traditional classification of colorectal polyps. The CMSEP is endoscopically characterised by elongated, worm-like appearance with a normal overlying mucosa. Histologic characteristics of the CMSEP comprise mucosa and expanded submucosa with dilated vasculature and lymphatics. Herein, we report a case of CMSEP, that to the best of our knowledge, has not been previously described in our literature. With regard to the on-going National colorectal cancer screening programme, our intention is to draw attention of gastrointestinal pathologists and endoscopists to this distinctive and very rare phenomenon.


    • 25 April 2015
      • Vol. 137, 30-3

    [Clinical characteristics of patients with a double pylori].

    by Hrvoje Iveković, Radovan Prijić, Bojana Radulović, Pave Markoš, Tomislav Brkić, Rajko Ostojić, Nadan Rustemović

    Double pylorus (DP), is a form of gastroduodenal fistula, which consists of a short accessory canal from the gastic antrum to the duodenal bulb, and mostly occrus in the background of peptic ulcer disease. Prevalence, as well long-term follow-up of patients with DP is less elucidated in western countries. Aim of our study was to analyse demografic, clinical and endoscopic characteristics in our case-series. During 2008-2013. a total of 23836 upper endoscopies were performed in 16759 patients. DP was diagnosed in 6 patients (prevalence of 0.04%). The follow-up period was f 8 to 72 months. In 87% DP was a complication of the upper gastrointestinal bleeding. In 83% cases opening of the fistula was on lesser curvature of gastric antrumu. During follow-up period the fistula healing did not occur in any of our patients. DP is a very rare entity, with a benign course of the disease Associated comorbidity and use of ulceriform medications plays important role in persistence of DP, wheras possible eradication of Helicobacter infection in this background remains elusive.

  • Mo1455 Accuracy of the Hue Histograms in the Evaluation of Patients With Pancreatic Masses. Do We Get More With Histogram Ratio?

    by Nadan Rustemovic, Milorad Opacic, Katja Grubelić Ravić, Zvonimir Ostojić, Dalibor OpačIć, Marko Brinar, Iva Ledinsky, ANA VIšNjić, Matea Majerović

    • 31 August 2012
      • Vol. 134, 141-7

    [Croatian guidelines for the management of pancreatic exocrine insufficiency].

    by Nadan Rustemović, Zeljko Krznarić, Darija Vranesić Bender, Rajko Ostojić, Silvija Cuković Cavka, Sandra Milić, Branimir Anić, Neven Ljubicić, Jasna Mesarić, Davor Stimac

    Pancreatic exocrine insufficiency is a major consequence of pancreatic diseases (e. g. chronic pancreatitis and cystic fibrosis), extrapancreatic diseases like celiac disease and Crohn's disease, and gastrointestinal and pancreatic surgical resections. Recognition of this entity is highly relevant to avoid malnutrition-related morbidity and mortality. The main clinical consequence of PEI is fat maldigestion and malabsorption, resulting in steatorrhoea. Pancreatic exocrine function should be assessed by measuring levels of faecal elastase-1. Pancreatic enzyme replacement therapy is the mainstay of treatment for PEI. Administration of enzymes in form of enteric-coated minimicrospheres avoids acid-mediated lipase inactivation and ensures gastric emptying of enzymes in parallel with nutrients. In adults, the initial recommended dose of pancreatic enzymes is 25.000 units of lipase per meal, titrating up to a maximum of 80000 units of lipase per meal. Large meals require 25.000 - 80.000 units of lipase per meal while snacks require 10.000 - 40.000 units of lipase per meal. Oral pancreatic enzymes should be taken with meals to ensure adequate mixing with the chyme. Adjunct therapy with acid-suppressing agents may be useful in patients who continue to experience symptoms of PEI despite high-dose enzyme therapy. Patients with PEI should be encouraged to consume small, frequent meals and to abstain from alcohol. Dietary fat restriction is not recommended for patients with PEI.

    • 24 April 2012
      • Vol. 134, 25-8

    [Intraductal papillary mucinous neoplasm of the pancreas: case report and review of the literature].

    by Hrvoje Iveković, Nadan Rustemović, Milorad Opacić, Ognjan Deban, Bosko Romic, Jasminka Jakić Razumović, Rajko Ostojić, Roland Pulanić, Boris Vucelić

    Intraductal papillary mucinous neoplasm (IPMN) of the pancreas is a relatively rare clinical entity with a main characteristic being mucus production. Extension of IPMN along pancretic ducts and mucus production lead to ductal obstruction and dilatation, resulting in recurrent episodes of acute pancreatitis. Molecular background of IPMN-a comprises several aberrations, with the K-ras gene mutation being the likely trigger that initiates further genetic changes. Due to its indolent nature, IPMN is most commonly diagnosed in the 7th decade of life. Depending on the histology type, IPMN has a malignant potential. Therefore, surgical therapy remains a "gold standard" of treatment. Insidious, slow progression of the disease and absence of symptoms in a certain number of patients makes diagnostic approach to this entity difficult. In this paper we present a patient with IPMN of the pancreas, in whom the episodes of acute pancreatitis had been present for 22 years.

    • 15 December 2011
      • Vol. 133, 322-6

    [Endoscopic mucosal resection of sessile polypoid colorectal lesions: a two-year retrospective study, technique description, indications and complications].

    by Pave Markos, Tomislav Brkić, Roland Pulanić, Jasenka Jakić-Razumović, Hrvoje Iveković, Marina Premuzić, Mirjana Kalauz, Milorad Opacić, Nadan Rustemović, Boris Vucelić

    Endoscopic mucosal resection (EMR) is a therapeutic method for removal of sesile premalignant lesions and intramucosal carcinoma of the gastrointestinal tract. No reports on EMR data in Croatia have been published yet. All patients included in the study were managed at the University Hospital Centre Zagreb between December 2006 and December 2008. EMR was performed using strip technique with submucosal injection of epinephrine (dilution with saline 1:5000-10000). EMR of sessile polypoid colorectal lesions was performed in 95 patients. The most common localisation of the disease was rectum (52 pts - 54.7%). In most patient size of the lesion was between 16-25 mm (43 pts - 45%). En-bloc resection was performed in 75 patients and piecemeal resection in the rest. Bleeding occurred immediately during the EMR in 5 pts (5.3%). Patohistological diagnosis revealed tubulovillous adenoma in 67 pts (70%). Invasive carcinoma was observed in 6 pts (6.3%) and intramucosal carcinoma in 20 pts (21%). On follow up, 73 pts (77%) did not show and sign of disease recurrence. Surgery was needed in 6 pts (6.3%) due to the diagnosis of invasive carcinoma. EMR is safe and reliable method with low risk of serious complications and acceptable recurrence rate.

  • Open Access

    A pilot study of transrectal endoscopic ultrasound elastography in inflammatory bowel disease

    by Nadan Rustemovic, Silvija Cukovic-Cavka, Marko Brinar, Davor Radić, Milorad Opacic, Rajko Ostojic, Boris Vucelic

    Using standard diagnostic algorithms it is not always possible to establish the correct phenotype of inflammatory bowel disease which is essential for therapeutical decisions. Endoscopic ultrasound elastography is a new endoscopic procedure which can differentiate the stiffness of normal and pathological tissue by ultrasound. Therefore, we aimed to investigate the role of transrectal ultrasound elastography in distiction between Crohn's disease and ulcerative colitis.


    • 6 September 2011
      • Vol. 133, 170-6

    [Consensus guidelines for diagnosis, treatment and follow-up of patients with gastrointestinal stromal tumors].

    by Nadan Rustemović, Jasminka Jakić-Razumović, Borislav Belev, Branka Petricević, Mate Skegro, Emil Kinda, Goran Augustin, Irena Hrstić, Rajko Ostojić, Ranka Stern-Padovan, et al.

    Gastrointestinal stromal tumors are the most common mesenchymal tumors in gastrointestinal tract. They are often asymptomatic and discovered incidentally during endoscopic or barium studies. About 80% GISTs have a KIT (CD 117 antigen) gene mutation. Most affect exon 11, less commonly exon 9,13 or 17, that results in uncontrolled KIT signaling. This led to effective systemic therapies in the form of small molecule inhibitors of the receptor tyrosine kinase such as imatinib mesylat. With the purpose of providing standardized approach to rational and effective diagnostic and treatment algorithm in Croatia, a multidisciplinary session was organized. Results of the session are given in the form of Consensus guidelines.


    • 4 August 2010
      • Vol. 132, 127-33

    [Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic neuroendocrine tumors].

    by Nadan Rustemović, Maja Cigrovski Berkovic, Vanja Zjacić-Rotkvić, Rajko Ostojić, Davor Hrabar, Jadranka Sertić, Jasminka Jakić-Razumović, Bozo Kruslin, Ranka Stern-Padovan, Stanko Tezak, et al.

    Pancreatic neuroendocrine tumors (PETs) are increasingly recognized. In order to assure an optimal treatment of patients and to propose an efficient diagnostic algorithm we were prompted to organize meetings, with participating experts, specialists in different fields of expertise. The idea for the meetings was to try to give a standardized approach, which would in future help in stratification of PET patients. Results of meetings are given in a form of Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic neuroendocrine tumors.